Aggregating human platelets stimulate expression of vascular endothelial growth factor in cultured vascular smooth muscle cells through a synergistic effect of transforming growth factor-β1 and platelet-derived growth factor(AB)

Circulation

Volumn 100, Issue 8, 1999, Pages 855-860

  Kronemann, Nicola ^a   Bouloumié, Anne ^a   Bassus, Steffen ^b   Kirchmaier, Carl M ^b   Busse, Rudi ^a   Schini Kerth, Valérie B ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Angiogenesis; Arteriosclerosis; Muscle, smooth; Platelet derived factors

Indexed keywords

MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTERIOSCLEROSIS; ARTICLE; BLOOD VESSEL INJURY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0033600535     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.8.855     Document Type: Article

References (29)

1. Vanhoutte PM. Endothelial dysfunction and atherosclerosis. Eur Heart J. 1997;18:E19-E29.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
3. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
4. 3 integrin, osteopontin, and thrombin. Am J Pathol. 1996;149:293-305.
5. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation. 1996;91: 2793-2801.
6. 165 gene transfer. Circulation. 1996;94:3291-3302.
7. Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, Kelly AB, Harker LA, Rao GN, Runge MS, Patterson C. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. Circ Res. 1997;81:24-33.
8. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner JM. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med. 1997;3:879-886.
9. AB. Circulation. 1997;96:3888-3896.
10. Pircher R, Jullien P, Lawrence DA. β-Transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun. 1986;136:30-37.
11. 145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem. 1997;272: 7151-7158.
12. Schini-Kerth VB, Fisslthaler B, Van Obberghen-Schilling E, Busse R. Serotonin stimulates the expression of thrombin receptors in cultured vascular smooth muscle cells: role of protein kinase C and protein tyrosine kinases. Circulation. 1996;93:2170-2177.
13. Scott-Burden T, Resink TJ, Baur U, Burgin M, Buhler FR. Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension. 1989;13:295-304.
14. BB in vascular smooth muscle cells. Eur J Pharmacol. 1992;216:379-383.
15. Schini VB, Catovsky S, Schray-Utz B, Busse R, Vanhoutte PM. Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells. Circ Res. 1994;74:24-32.
16. Wakefield LM, Smith DM, Flanders KC, Sporn MB. Latent transforming growth factor-β from human platelets: a high molecular weight complex containing precursor sequences. J Biol Chem. 1988;263:7646-7654.
17. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;13:18-32.
18. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation. 1994; 90:649-652.
19. Ferrara N, Winer J, Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors. 1991;5: 141-148.
20. Sachinidis A, Locher R, Vetter W, Tatje D, Hoppe J. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem. 1990;265:10238-10243.
21. Groves HM, Kinlough-Rathbone RL, Richardson M, Moore S, Mustard JF. Platelet interaction with damaged rabbit aorta. Lab Invest. 1979;40: 194-200.
22. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
23. 1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.
24. Lindner V, Reidy A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
25. Laporte S, Escher E. Neointima formation after vascular injury is angiotensin II mediated. Biochem Biophvs Res Commun. 1992;187: 1510-1516.
26. Chandra S, Clark LV, Coatney RW, Phan L, Sarkar SK, Ohlstein EH. Application of serial in vivo magnetic resonance imaging to evaluate the efficacy of endothelin receptor antagonist SB 217242 in the rat carotid artery model of neointima formation. Circulation. 1998;97:2252-2258.
27. Li J, Perrella MA, Tsai JC, Yet SF, Hsieh CM, Yoshizumi M, Patterson C, Endege WO, Zhou F, Lee ME. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J Biol Chem. 1995;270:308-312.
28. Williams B, Baker AQ, Gallacher B, Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension. 1995;25:913-917.
29. Pedram A, Razandi M, Hu RM, Levin ER. Vasoactive peptides modulate vascular endothelial growth factor production and endothelial cell proliferation and invasion. J Biol Chem. 1997;272:17097-17103.